Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (10): 1008-1011.DOI: 10.3969/j.issn.1673-8640.2021.010.003
Previous Articles Next Articles
GUO Ping1, CHANG Jinghua2, WANG Jianbiao1()
Received:
2021-03-09
Online:
2021-10-30
Published:
2021-11-08
Contact:
WANG Jianbiao
CLC Number:
GUO Ping, CHANG Jinghua, WANG Jianbiao. Retrospective analysis of a case of green neutrophil and monocyte inclusions with malaria pigment[J]. Laboratory Medicine, 2021, 36(10): 1008-1011.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.010.003
项目 | 检测值 | 参考区间 |
---|---|---|
白细胞计数/(×109/L) | 5.62 | 3.97~9.15 |
红细胞计数/(×1012/L) | 4.97 | 4.09~5.74 |
血红蛋白/(g/L) | 153 | 131~172 |
血小板计数/(×109/L) | 12 | 85~303 |
中性粒细胞百分比/% | 82.7 | 50.0~70.0 |
淋巴细胞百分比/% | 9.7 | 20.0~40.0 |
C反应蛋白/(mg/L) | >200 | <10 |
总胆红素/(μmol/L) | 71.3 | 4.7~24.0 |
直接胆红素/(μmol/L) | 24.8 | 0~6.8 |
丙氨酸氨基转移酶/(IU/L) | 65 | 10~64 |
天门冬氨酸氨基转移酶/(IU/L) | 51 | 8~40 |
白蛋白/(g/L) | 37 | 35~55 |
尿素/(mmol/L) | 9.7 | 2.5~7.1 |
肌酐/(μmol/L) | 112 | 53~97 |
项目 | 检测值 | 参考区间 |
---|---|---|
白细胞计数/(×109/L) | 5.62 | 3.97~9.15 |
红细胞计数/(×1012/L) | 4.97 | 4.09~5.74 |
血红蛋白/(g/L) | 153 | 131~172 |
血小板计数/(×109/L) | 12 | 85~303 |
中性粒细胞百分比/% | 82.7 | 50.0~70.0 |
淋巴细胞百分比/% | 9.7 | 20.0~40.0 |
C反应蛋白/(mg/L) | >200 | <10 |
总胆红素/(μmol/L) | 71.3 | 4.7~24.0 |
直接胆红素/(μmol/L) | 24.8 | 0~6.8 |
丙氨酸氨基转移酶/(IU/L) | 65 | 10~64 |
天门冬氨酸氨基转移酶/(IU/L) | 51 | 8~40 |
白蛋白/(g/L) | 37 | 35~55 |
尿素/(mmol/L) | 9.7 | 2.5~7.1 |
肌酐/(μmol/L) | 112 | 53~97 |
[1] | BUCK E, FINNIGAN N A. Malaria[J]. Treasure Island(FL),2021. |
[2] |
COURVILLE E L, CRISMAN S, LINDEN M A, et al. Green neutrophilic inclusions are frequently associated with liver injury and may portend short-term mortality in critically ill patients[J]. Lab Med, 2017, 48(1):18-23.
DOI URL |
[3] | HABERICHTER K L, CRISAN D. Green neutrophilic inclusions and acute hepatic failure:clinical significance and brief review of the literature[J]. Ann Clin Lab Sci, 2017, 47(1):58-61. |
[4] | CANTU M D, TOWNE W S, EMMONS F N, et al. Clinical significance of blue-green neutrophil and monocyte cytoplasmic inclusions in SARS-CoV-2 positive critically ill patients[J]. Br J Haematol, 2020, 190(2):e89-e92. |
[5] |
HARRIS V N, MALYSZ J, SMITH M D. Green neutrophilic inclusions in liver disease[J]. J Clin Pathol, 2009, 62(9):853-854.
DOI URL |
[6] |
MCGINNIS E, SMITH T W. Clostridium perfringens sepsis with spherocytosis and green neutrophil inclusions[J]. Br J Haematol, 2020, 190(5):641.
DOI URL |
[7] |
YANG J, GABALI A. Green neutrophilic inclusions:current understanding and review of literature[J]. Curr Opin Hematol, 2018, 25(1):3-6.
DOI URL |
[8] |
HODGSON T O, RUSKOVA A, SHUGG C J, et al. Green neutrophil and monocyte inclusions-time to acknowledge and report[J]. Br J Haematol, 2015, 170(2):229-235.
DOI URL |
[9] |
BRUNK U, ERICSSON J L. Electron microscopical studies on rat brain neurons. Localization of acid phosphatase and mode of formation of lipofuscin bodies[J]. J Ultrastruct Res, 1972, 38(1):1-15.
DOI URL |
[10] |
SEEHAFER S S, PEARCE D A. You say lipofuscin,we say ceroid:defining autofluorescent storage material[J]. Neurobiol Aging, 2006, 27(4):576-588.
DOI URL |
[11] |
TERMAN A, BRUNK U T. Lipofuscin[J]. Int J Biochem Cell Biol, 2004, 36(8):1400-1404.
DOI URL |
[12] |
KISHI M, MAEYAMA S, KOIKE J, et al. Correlation between intrasinusoidal neutrophilic infiltration and ceroid-lipofuscinosis in alcoholic liver fibrosis with or without fatty change:clinicopathological comparison with nutritional fatty liver[J]. Alcohol Clin Exp Res, 1996, 20(9 Suppl):366A-370A.
DOI URL |
[13] |
MOIZ B, ALI S S. Intraleucocytic haemozoin-a biomarker for severe malaria[J]. Br J Haematol, 2016, 172(3):313.
DOI URL |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||